The Biological Products Industry Alliance (BPIA) submitted comments in response to the U.S. Department of Justice’s Request for Information on State Laws Having Significant Adverse Effects on the National Economy or Significant Adverse Effects on Interstate Commerce (Docket ID OLP182). BPIA’s comments highlight how inconsistent state regulation of biological products—particularly plant biostimulants and biopesticides—creates unnecessary barriers to interstate commerce, increases costs for small businesses, and delays grower access to innovative tools. The submission emphasizes the need for regulatory clarity and harmonization at the federal level, noting how initiatives such as the Plant Biostimulant Act of 2025 can help establish a uniform national framework. BPIA underscored that streamlined policies will strengthen the domestic biologicals sector, support American jobs, and ensure U.S. farmers remain competitive globally. See BPIA Comments 091525
